 | • レポートコード：MRC2303E097 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、225ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料は、2021年に3,291.23百万ドルであった世界の動物用リファレンスラボラトリー市場規模が、2022年に3,751.34百万ドルになり、2027年まで年平均14.23%で成長して7,313.95百万ドルに到達すると予想しています。本レポートでは、動物用リファレンスラボラトリーの世界市場を広く調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、サービス種類別（臨床化学サービス、血液学サービス、免疫診断サービス、分子診断サービス、その他）分析、動物別（コンパニオンアニマル、畜産動物）分析、用途別（細菌学、臨床病理学、寄生虫学、妊娠検査、生産性試験）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目を掲載しています。また、参入企業情報として、Animal and Plant Health Agency、Boehringer Ingelheim International GmbH、Genesis Biotechnology Group, LLC、Gezondheidsdienst voor Dieren B.V.、Greencross Limited、Gribbles Veterinary、IDEXX Laboratories, Inc.、LABOKLIN Laboratory for Clinical Diagnostics GmbH & Co. KG、Mars, Incorporated、Marshfield Clinic Health System、Neogen Corporation、Phoenix Labs Inc.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の動物用リファレンスラボラトリー市場規模：サービス種類別 - 臨床化学サービスの市場規模 - 血液学サービスの市場規模 - 免疫診断サービスの市場規模 - 分子診断サービスの市場規模 - その他サービスの市場規模 ・世界の動物用リファレンスラボラトリー市場規模：動物別 - コンパニオンアニマルにおける市場規模 - 畜産動物における市場規模 ・世界の動物用リファレンスラボラトリー市場規模：用途別 - 細菌学における市場規模 - 臨床病理学における市場規模 - 寄生虫学における市場規模 - 妊娠検査における市場規模 - 生産性試験における市場規模 ・世界の動物用リファレンスラボラトリー市場規模：地域別 - 南北アメリカの動物用リファレンスラボラトリー市場規模 アメリカの動物用リファレンスラボラトリー市場規模 カナダの動物用リファレンスラボラトリー市場規模 ブラジルの動物用リファレンスラボラトリー市場規模 ... - アジア太平洋の動物用リファレンスラボラトリー市場規模 日本の動物用リファレンスラボラトリー市場規模 中国の動物用リファレンスラボラトリー市場規模 インドの動物用リファレンスラボラトリー市場規模 韓国の動物用リファレンスラボラトリー市場規模 台湾の動物用リファレンスラボラトリー市場規模 ... -ヨーロッパ/中東/アフリカの動物用リファレンスラボラトリー市場規模 イギリスの動物用リファレンスラボラトリー市場規模 ドイツの動物用リファレンスラボラトリー市場規模 フランスの動物用リファレンスラボラトリー市場規模 ロシアの動物用リファレンスラボラトリー市場規模 ... -その他地域の動物用リファレンスラボラトリー市場規模 ・競争状況 ・企業情報 |
The Global Veterinary Reference Laboratory Market size was estimated at USD 3,291.23 million in 2021 and expected to reach USD 3,751.34 million in 2022, and is projected to grow at a CAGR 14.23% to reach USD 7,313.95 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Veterinary Reference Laboratory to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type of Service, the market was studied across Clinical Chemistry Services, Hematology Services, Immunodiagnostic Services, Molecular Diagnostic Services, Other Services, and Urinalysis Services.
Based on Animal, the market was studied across Companion Animals and Livestock Animals. The Companion Animals is further studied across Cats, Dogs, Horses, and Other Companion Animals. The Livestock Animals is further studied across Cattle, Other Livestock Animals, Pigs, and Poultry.
Based on Application, the market was studied across Bacteriology, Clinical Pathology, Parasitology, Pregnancy Testing, Productivity Testing, Toxicology, and Virology.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Veterinary Reference Laboratory market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Veterinary Reference Laboratory Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Veterinary Reference Laboratory Market, including Animal and Plant Health Agency, Boehringer Ingelheim International GmbH, Genesis Biotechnology Group, LLC, Gezondheidsdienst voor Dieren B.V., Greencross Limited, Gribbles Veterinary, IDEXX Laboratories, Inc., LABOKLIN Laboratory for Clinical Diagnostics GmbH & Co. KG, Mars, Incorporated, Marshfield Clinic Health System, Neogen Corporation, Phoenix Labs Inc., Protatek Reference Laboratory, Sanofi, SYNLAB International GmbH, TVMDL Texas A&M Veterinary Medical Diagnostic Laboratory, VCA, Inc., Virbac S.A., Washington Animal Disease Diagnostic Lab, and Zoetis Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Veterinary Reference Laboratory Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Veterinary Reference Laboratory Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Veterinary Reference Laboratory Market?
4. What is the competitive strategic window for opportunities in the Global Veterinary Reference Laboratory Market?
5. What are the technology trends and regulatory frameworks in the Global Veterinary Reference Laboratory Market?
6. What is the market share of the leading vendors in the Global Veterinary Reference Laboratory Market?
7. What modes and strategic moves are considered suitable for entering the Global Veterinary Reference Laboratory Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growth in the companion animal population and demand for pet insurance
5.1.1.2. Increasing incidence of transboundary and zoonotic diseases in the pets
5.1.1.3. Rising adoption of pets in the developing economies
5.1.2. Restraints
5.1.2.1. Increasing pet care costs with rising demand for rapid tests, POC testing, and portable instruments
5.1.3. Opportunities
5.1.3.1. Emergence of technologically advanced veterinary reference laboratory for better pet care and reduced cost in the testing of the pet diseases
5.1.3.2. Rising public-private partnerships for the improvement of veterinary health
5.1.3.3. Growing demand for animal-derived food products and increasing the use for PCR testing panels
5.1.4. Challenges
5.1.4.1. Lack of awareness and weak functional and infrastructural capacities
5.2. Cumulative Impact of COVID-19
6. Veterinary Reference Laboratory Market, by Type of Service
6.1. Introduction
6.2. Clinical Chemistry Services
6.3. Hematology Services
6.4. Immunodiagnostic Services
6.5. Molecular Diagnostic Services
6.6. Other Services
6.7. Urinalysis Services
7. Veterinary Reference Laboratory Market, by Animal
7.1. Introduction
7.2. Companion Animals
7.3.1. Cats
7.3.2. Dogs
7.3.3. Horses
7.3.4. Other Companion Animals
7.3. Livestock Animals
7.4.1. Cattle
7.4.2. Other Livestock Animals
7.4.3. Pigs
7.4.4. Poultry
8. Veterinary Reference Laboratory Market, by Application
8.1. Introduction
8.2. Bacteriology
8.3. Clinical Pathology
8.4. Parasitology
8.5. Pregnancy Testing
8.6. Productivity Testing
8.7. Toxicology
8.8. Virology
9. Americas Veterinary Reference Laboratory Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Veterinary Reference Laboratory Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Veterinary Reference Laboratory Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Animal and Plant Health Agency
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Boehringer Ingelheim International GmbH
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Genesis Biotechnology Group, LLC
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Gezondheidsdienst voor Dieren B.V.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Greencross Limited
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Gribbles Veterinary
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. IDEXX Laboratories, Inc.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. LABOKLIN Laboratory for Clinical Diagnostics GmbH & Co. KG
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Mars, Incorporated
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Marshfield Clinic Health System
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Neogen Corporation
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Phoenix Labs Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Protatek Reference Laboratory
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Sanofi
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. SYNLAB International GmbH
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. TVMDL Texas A&M Veterinary Medical Diagnostic Laboratory
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. VCA, Inc.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Virbac S.A.
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Washington Animal Disease Diagnostic Lab
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Zoetis Inc.
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing